Gf Fund Management Co. Ltd. Avidity Biosciences, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,055 shares of RNA stock, worth $99,745. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,055
Previous 2,505
21.96%
Holding current value
$99,745
Previous $72.8 Million
23.8%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
262Shares Held
100MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$361 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$308 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$282 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$259 Million3.76% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.5MShares$245 Million3.18% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.7B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...